Form 4 for KURA Kura Oncology, Inc.
Accepted 2026-01-27 00:00:00 ET · period of report 2026-01-27 · accession 0001193125-26-025302 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-27 | 2026-01-27 | KURA | DOYLE THOMAS JAMES | SVP, Fin, Accounting | S - Sale | $8.46 | -7,142 | 150.1K | -5% | -$60.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-27 | S | D | 1,114 | $8.46 | 148,969 | D | — | — | (F2) Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. |
| 2 | Common | Common Stock | 2026-01-27 | S | D | 695 | $8.46 | 148,274 | D | — | — | (F3) Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. |
| 3 | Common | Common Stock | 2026-01-27 | S | D | 2,226 | $8.46 | 146,048 | D | — | — | (F4) Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25. |
| 4 | Common | Common Stock | 2026-01-27 | S | D | 881 | $8.46 | 145,167 | D | — | — | (F5) Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22. |
| 5 | Common | Common Stock | 2026-01-27 | S | D | 2,226 | $8.46 | 150,083 | D | — | — | (F1) Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. |